Skip to content

Development of Dietary Supplements for Mood Symptoms in Postpartum

Development of Dietary Supplements for Mood Symptoms in Postpartum

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02073175
Enrollment
28
Registered
2014-02-27
Start date
2014-02-28
Completion date
2016-04-30
Last updated
2016-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Postpartum Blues

Keywords

Postpartum, Dietary Supplements, Mood Symptoms

Brief summary

The purpose of this study is to determine whether a dietary supplement (DS) is effective in protecting against sad mood in postpartum.

Detailed description

The specific aim of this open-label study is to assess whether the proposed dietary supplement can reduce the intensity of sadness in women vulnerable to sadness (day-5 postpartum women and women within the first 18 months postpartum with crying spells).

Interventions

The interventions involves a dietary supplement called Motherwell, at current stage, to reduce the intensity of sadness in women vulnerable to sadness.

Sponsors

Centre for Addiction and Mental Health
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 to 45 * The subject, as reported by them, should be in a good health. * The subject is not taking any medication. * The subject is not taking any investigational medicinal product within 8 weeks. * BMI 19 to 40 (kg/m2) * Resting pulse between 45 and 100 bpm * Systolic blood pressure between 91 and 139 mmHg (inclusive) * Diastolic blood pressure between 51 and 90 mmHg (inclusive)

Exclusion criteria

* The subject has been diagnosed with any axis 1 and 2 disorders based on Structured Clinical Interview (SCID) for DSM-IV interview. * Substance abuse disorder * Subjects who have been smoking in the past 5 years.

Design outcomes

Primary

MeasureTime frameDescription
Change in Visual Analog Scale (VAS)Assessment will be done on day-5 postpartum or within the first 18 months postpartum (depending on which group subject belongs to). On the assessment day, the VAS will be administered before and after sad mood indcution and comparedVAS uses a 10-cm scale for participants to indicate the extent to which each of them feel happy or sad. The change in VAS before versus after sad mood induction is the change score in VAS. The change score on the day with active dietary supplement is compare to the change score of the subjects who have not received any supplement and have been recently recruited

Secondary

MeasureTime frameDescription
Change in Profile of Mood States (POMS) ScoresAssessment will be done on day-5 postpartum or within the first 18 months postpartum (depending on which group subject belongs to). On the assessment day, the POMS will be administered before and after sad mood indcution and comparedThe POMS contains 65 adjectives rated by participants on a 5-point scale. Six factors are derived that include tension, depression, anger, fatigue, vigor and confusion.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026